Assessment of copy number status of chromosomes 6 and 11 by FISH provides independent prognostic information in primary melanoma

Jeffrey P. North, John Vetto, Rajmohan Murali, Kevin White, Clifton White, Boris C. Bastian

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Melanoma incidence has been rising steadily for decades, whereas mortality rates have remained flat. This type of discordant pattern between incidence and mortality has been linked to diagnostic drift in cancers of the thyroid, breast, and prostate. Ancillary tests, such as fluorescent in situ hybridization (FISH), are now being used to help differentiate melanomas from melanocytic nevi. Multicolor FISH has been shown to distinguish between these 2 with 86.7% sensitivity and 95.4% specificity. To assess the ability of FISH to differentiate melanomas with metastatic or lethal potential from those with an indolent disease course, we performed FISH with probes targeting 6p25, centromere 6, 6q23, and 11q13 on 144 primary melanomas with a minimal tumor thickness of 2 mm and compared the development of metastatic disease and melanoma-specific mortality as well as relapse-free and disease-specific survival between FISH-positive and FISH-negative cases. Of the melanomas, 82% were positive by FISH according to previously defined criteria. The percentage was significantly higher (93%) in cases that developed systemic metastases (n=43) than in patients that did not (77%, n=101). FISH-positive primaries had a significantly increased risk of metastasis or melanoma-related death compared with FISH-negative cases odds ratio 4.11; confidence interval, 1.14-22.7 and odds ratio 7.0, confidence interval 1.03-300.4, respectively. FISH status remained an independent parameter when controlling for known prognostic factors. These data indicate that the group of melanomas diagnosed with routine histopathology that lack aberrations detected by FISH is enriched for melanomas with a more indolent disease course. This suggests that molecular techniques can assist in a more accurate identification of tumors with metastatic potential.

Original languageEnglish (US)
Pages (from-to)1146-1150
Number of pages5
JournalAmerican Journal of Surgical Pathology
Volume35
Issue number8
DOIs
StatePublished - Aug 2011

Fingerprint

Chromosomes, Human, Pair 11
Chromosomes, Human, Pair 6
Fluorescence In Situ Hybridization
Melanoma
Mortality
Odds Ratio
Confidence Intervals
Neoplasm Metastasis
Pigmented Nevus
Centromere
Incidence
Thyroid Neoplasms
Disease-Free Survival
Neoplasms
Prostatic Neoplasms
Breast Neoplasms

Keywords

  • ambiguity
  • FISH
  • fluorescent in situ hybridization
  • melanoma
  • overdiagnosis
  • prognosis

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine
  • Surgery

Cite this

Assessment of copy number status of chromosomes 6 and 11 by FISH provides independent prognostic information in primary melanoma. / North, Jeffrey P.; Vetto, John; Murali, Rajmohan; White, Kevin; White, Clifton; Bastian, Boris C.

In: American Journal of Surgical Pathology, Vol. 35, No. 8, 08.2011, p. 1146-1150.

Research output: Contribution to journalArticle

@article{ba92adfae4d545da8f1b3153312a0e0b,
title = "Assessment of copy number status of chromosomes 6 and 11 by FISH provides independent prognostic information in primary melanoma",
abstract = "Melanoma incidence has been rising steadily for decades, whereas mortality rates have remained flat. This type of discordant pattern between incidence and mortality has been linked to diagnostic drift in cancers of the thyroid, breast, and prostate. Ancillary tests, such as fluorescent in situ hybridization (FISH), are now being used to help differentiate melanomas from melanocytic nevi. Multicolor FISH has been shown to distinguish between these 2 with 86.7{\%} sensitivity and 95.4{\%} specificity. To assess the ability of FISH to differentiate melanomas with metastatic or lethal potential from those with an indolent disease course, we performed FISH with probes targeting 6p25, centromere 6, 6q23, and 11q13 on 144 primary melanomas with a minimal tumor thickness of 2 mm and compared the development of metastatic disease and melanoma-specific mortality as well as relapse-free and disease-specific survival between FISH-positive and FISH-negative cases. Of the melanomas, 82{\%} were positive by FISH according to previously defined criteria. The percentage was significantly higher (93{\%}) in cases that developed systemic metastases (n=43) than in patients that did not (77{\%}, n=101). FISH-positive primaries had a significantly increased risk of metastasis or melanoma-related death compared with FISH-negative cases odds ratio 4.11; confidence interval, 1.14-22.7 and odds ratio 7.0, confidence interval 1.03-300.4, respectively. FISH status remained an independent parameter when controlling for known prognostic factors. These data indicate that the group of melanomas diagnosed with routine histopathology that lack aberrations detected by FISH is enriched for melanomas with a more indolent disease course. This suggests that molecular techniques can assist in a more accurate identification of tumors with metastatic potential.",
keywords = "ambiguity, FISH, fluorescent in situ hybridization, melanoma, overdiagnosis, prognosis",
author = "North, {Jeffrey P.} and John Vetto and Rajmohan Murali and Kevin White and Clifton White and Bastian, {Boris C.}",
year = "2011",
month = "8",
doi = "10.1097/PAS.0b013e318222a634",
language = "English (US)",
volume = "35",
pages = "1146--1150",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Assessment of copy number status of chromosomes 6 and 11 by FISH provides independent prognostic information in primary melanoma

AU - North, Jeffrey P.

AU - Vetto, John

AU - Murali, Rajmohan

AU - White, Kevin

AU - White, Clifton

AU - Bastian, Boris C.

PY - 2011/8

Y1 - 2011/8

N2 - Melanoma incidence has been rising steadily for decades, whereas mortality rates have remained flat. This type of discordant pattern between incidence and mortality has been linked to diagnostic drift in cancers of the thyroid, breast, and prostate. Ancillary tests, such as fluorescent in situ hybridization (FISH), are now being used to help differentiate melanomas from melanocytic nevi. Multicolor FISH has been shown to distinguish between these 2 with 86.7% sensitivity and 95.4% specificity. To assess the ability of FISH to differentiate melanomas with metastatic or lethal potential from those with an indolent disease course, we performed FISH with probes targeting 6p25, centromere 6, 6q23, and 11q13 on 144 primary melanomas with a minimal tumor thickness of 2 mm and compared the development of metastatic disease and melanoma-specific mortality as well as relapse-free and disease-specific survival between FISH-positive and FISH-negative cases. Of the melanomas, 82% were positive by FISH according to previously defined criteria. The percentage was significantly higher (93%) in cases that developed systemic metastases (n=43) than in patients that did not (77%, n=101). FISH-positive primaries had a significantly increased risk of metastasis or melanoma-related death compared with FISH-negative cases odds ratio 4.11; confidence interval, 1.14-22.7 and odds ratio 7.0, confidence interval 1.03-300.4, respectively. FISH status remained an independent parameter when controlling for known prognostic factors. These data indicate that the group of melanomas diagnosed with routine histopathology that lack aberrations detected by FISH is enriched for melanomas with a more indolent disease course. This suggests that molecular techniques can assist in a more accurate identification of tumors with metastatic potential.

AB - Melanoma incidence has been rising steadily for decades, whereas mortality rates have remained flat. This type of discordant pattern between incidence and mortality has been linked to diagnostic drift in cancers of the thyroid, breast, and prostate. Ancillary tests, such as fluorescent in situ hybridization (FISH), are now being used to help differentiate melanomas from melanocytic nevi. Multicolor FISH has been shown to distinguish between these 2 with 86.7% sensitivity and 95.4% specificity. To assess the ability of FISH to differentiate melanomas with metastatic or lethal potential from those with an indolent disease course, we performed FISH with probes targeting 6p25, centromere 6, 6q23, and 11q13 on 144 primary melanomas with a minimal tumor thickness of 2 mm and compared the development of metastatic disease and melanoma-specific mortality as well as relapse-free and disease-specific survival between FISH-positive and FISH-negative cases. Of the melanomas, 82% were positive by FISH according to previously defined criteria. The percentage was significantly higher (93%) in cases that developed systemic metastases (n=43) than in patients that did not (77%, n=101). FISH-positive primaries had a significantly increased risk of metastasis or melanoma-related death compared with FISH-negative cases odds ratio 4.11; confidence interval, 1.14-22.7 and odds ratio 7.0, confidence interval 1.03-300.4, respectively. FISH status remained an independent parameter when controlling for known prognostic factors. These data indicate that the group of melanomas diagnosed with routine histopathology that lack aberrations detected by FISH is enriched for melanomas with a more indolent disease course. This suggests that molecular techniques can assist in a more accurate identification of tumors with metastatic potential.

KW - ambiguity

KW - FISH

KW - fluorescent in situ hybridization

KW - melanoma

KW - overdiagnosis

KW - prognosis

UR - http://www.scopus.com/inward/record.url?scp=79961029844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79961029844&partnerID=8YFLogxK

U2 - 10.1097/PAS.0b013e318222a634

DO - 10.1097/PAS.0b013e318222a634

M3 - Article

C2 - 21716079

AN - SCOPUS:79961029844

VL - 35

SP - 1146

EP - 1150

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 8

ER -